API
< Back to situations

[ORGANIZATION]

Enveda

Featured in 6 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

320 clusters · 1171 sources · last updated

Latest: GLP-1 weight-loss drugs may exacerbate eating disorders

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. However, safety concerns are

[ACTIVE] [HEALTH] [BR] [ES] [DE]

Sarcopenia Prevention and Muscle-Preserving Trends

19 clusters · 59 sources · last updated

Latest: Sarcopenia prevention requires combining protein with strength training

By late October 2026, medical focus has intensified on managing sarcopenia, the progressive loss of muscle mass and strength that typically accelerates after age 50 or 60. A significant clinical challenge exists for pati